Stock Symbol:
CTLT
Case Status:
Investigations
Ademi LLP is investigating Catalent (NYSE: CTLT) for possible breaches of fiduciary duty and other violations of law in its transaction with Novo Holdings.
In the transaction, Catalent shareholders will receive only $63.50 in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis. The transaction agreement unreasonably limits competing transactions for Catalent by imposing a significant penalty if Catalent accepts a competing bid. Catalent insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Catalent’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.